If you have daily living and/or mobility needs due to a sight condition or poor vision, you may be able to claim benefits.

Nanoscope Therapeutics begins rolling submission of BLA to US FDA for gene-agnostic therapy, MCO-010 to treat retinitis pigmentosa: Dallas, Texas Wednesday, July 16, 2025, 14:30 H ...

If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

A girl from Stevenage who has an incurable eye disease has undergone a pioneering gene therapy which has allowed her to see in the dark and ...

Similar data from Social Security Scotland indicates there are now 2,010 people receiving ADP for an eye condition. An estimated 188,000 people in Scotland are affected by some form of sight loss with ...

DALLAS, TX, USA I July 14, 2025 I Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic ...

Nanoscope Therapeutics submitted the first modules of a biologics license application for MCO-010, an investigational gene ...

Nanoscope’s BLA has been granted rolling review by the FDA, with the first modules already submitted. The completion of the ...

Jenny Stafford, who has retinitis pigmentosa, completed her 250th parkrun in Jersey and says the regular activity makes a huge difference to her week. | ITV News Channel ...

Female sex hormones can significantly enhance the progression of the rare neurodegenerative eye disease retinitis pigmentosa (RP), according to a preclinical study by researchers at UT Southwestern ...

The term retinitis pigmentosa (RP) describes a large group of hereditary retinopathies. From a cellular view, retinal degeneration is prompted by an initial death of rods, followed later by cone ...

In her project, she will study the eye disease Retinitis Pigmentosa (RP), which is a genetic disease leading to vision loss ...